The landscape of dementia prognosis has evolved drastically with the advent of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly tests which can detect Alzheimer's pathology several years prior to signs and symptoms arise. Though these technological advances depict remarkable development in being familiar with neurodegenerative https://vant752qaj2.wikicommunication.com/user